Actilyse 50mg Injection

Actilyse 50mg Injection contains an active component as Alteplase. It is also known as recombinant tissue plasminogen activator (rt-PA), used to treat certain medical conditions involving blood clots. It is a thrombolytic agent, meaning it helps to break down blood clots. This medication is commonly used to manage acute ischemic strokes, where a blood clot blocks blood flow to the brain, leading to potential brain damage. By administering atelpase within a specific time frame after the onset of stroke symptoms, doctors aim to restore blood flow to the affected brain tissue and reduce the risk of long-term disability. By restoring blood flow to the affected brain area, Actilyse 50mg injection can help minimize the extent of brain tissue damage caused by the stroke. This can lead to a reduction in long-term disability and an improved chance of recovery for stroke patients. As with any medication, this medication can have side effects, and it may not be suitable for every patient. Common side effects include bleeding, particularly in the brain or gastrointestinal tract. Before administering it, usually, doctors assess the patient’s medical history and consider any contraindications.

Patients who have a known allergy or hypersensitivity to Actilyse 50mg injection or any of its components should not receive this medication. Patients with significant trauma (head trauma or internal injuries) within the past three months due to an increased risk of bleeding should avoid this medication. This medication is cleared from the body through the liver and kidneys, so caution is advised in patients with severe liver or kidney impairment. Advanced age can increase the risk of bleeding complications with this medication, particularly in patients over 75.